HF-REACH: Bringing Heart Failure Care Closer to Home in Regional Queensland

HF-REACH (Heart Failure – Remote Engagement, Access and Care at Home) is a digitally enabled, nurse-led clinical trial designed to improve access to structured heart failure care for people living in regional, rural, and remote communities.

Patients are supported remotely by a specialised cardiac nursing team who monitor symptoms, weight, blood pressure, heart rate, and medication adherence. Nurses provide education and self-management support, identify potential deterioration early, and escalate clinical concerns to the patient’s GP or cardiologist when required.

For participating general practices, HF-REACH is designed to support rather than add to existing chronic disease care. The central research team coordinates study screening, consent, remote monitoring and research activities, while the patient’s local clinician remains responsible for their usual clinical care.

Benefits for participating practices and clinicians may include:

  • Additional specialised heart failure nursing support for patients
  • Earlier identification and escalation of clinical deterioration
  • Improved coordination between patients, GPs and cardiac services
  • Opportunities to participate in rural and regional clinical research and build research capability
  • Potential access to Teletrial Program support for eligible participating sites
  • Opportunities for CPD and quality-improvement activities, where applicable.

HF-REACH aligns strongly with Queensland’s focus on improving heart failure outcomes, strengthening care across hospital and community settings and reducing avoidable hospitalisations.

We invite GP practices in regional Queensland to partner with HF-REACH to connect interested regional practices and clinicians with the program and help expand access to heart failure research and digitally enabled care closer to home.

* Research project closes:

Sat, 31 July 2027

Research project details

Research by

HREC info

Name of the approving Human Research Ethics Committee (HREC): Bellberry
Ethics approval reference number: 2026-06-106

Reimbursement info

Eligible regional GP practices participating as Teletrial Satellite Sites may receive Australian Teletrial Program support payments to help offset the time and resources involved in trial participation. Under the Teletrial Support Program framework, eligible Satellite Sites may receive: Up to $700 (GST exclusive) per eligible participant per year for participants residing in Modified Monash Model (MM) 2–7 locations, subject to Teletrial Support Program eligibility and jurisdictional arrangements. For HF-REACH, with a six-month participant follow-up, this could provide up to $700 in Teletrial support per eligible participant recruited through a participating regional practice, subject to confirmation of eligibility.